Use Cases

The system is the same.
What changes is where you are.

KEEP operates across the full therapy lifecycle. Select your stage.

Stage 01
Pre-Launch
You're designing for patients you've never met. Every assumption you make now is harder to reverse after launch.
See the stage
Stage 02
Early Commercial
Your brand is live. The gap between what you built and what patients experience is already forming.
See the stage
Stage 03
Lifecycle Management
Your brand has traction. The signals that matter now are quiet — and by the time they're visible, you're already behind.
See the stage
Clinical
Pre-Launch
Early Commercial
Lifecycle Management
LOE
01
Stage One

Pre-Launch

You are designing for patients you have never met. Every decision made now will be harder to reverse after launch.

Where you are
24mo
Pre-launch windowThe highest-leverage moment. Decisions lock. Patient signal is the only way to validate assumptions before it's too late.
Competitive landscape
Dissatisfaction signals
Segmentation validation
What KEEP changes
Understand what patients on standard of care are actually experiencing — before your first patient is treated
Validate segmentation, positioning, and HCP messaging against real signal before decisions lock
Know where the dissatisfaction is and where the openings are before launch day
Build a patient baseline that makes every future commercial decision faster and defensible
What you walk away with
A patient narrative built from real experience — not advisory board assumptions
Competitive intelligence grounded in what patients on other brands are actually saying
A launch strategy your brand team can execute with confidence because the signal is real
Illustrative example
The positioning changed before the first patient was treated.

A commercial team preparing to launch a rare autoimmune treatment had built their go-to-market on physician advisory boards and secondhand intelligence. Eighteen months from approval, they still didn't have a clear picture of what patients on standard of care were actually experiencing day to day.

KEEP enrolled patients already living in that therapy area. Within two quarterly reports, the team learned that the most common reason patients tolerated a suboptimal standard of care wasn't lack of awareness — it was fear of disrupting a routine they'd spent years building around a disease that had already taken enough.

The narrative shifted from efficacy to stability. Field messaging was rewritten. The brand launched with a patient story it couldn't have told without being present for it.

Illustrative example based on real program patterns.
02
Stage Two

Early Commercial

Your brand is live. Claims data will confirm the gap in six months. By then, the window to respond will have narrowed significantly.

Where you are
90day
Critical dropout windowMost early-commercial patient loss happens here — before claims data can explain why. KEEP sees it forming in real time.
Drift signals
Narrative resonance
Dropout risk
What KEEP changes
Bridge the gap between clinical narrative and patient reality before it becomes a performance problem
Surface inflection points as they emerge — not months after the fact
Arm field teams with language that reflects what patients are actually experiencing
Catch drift and early disengagement signals weeks before they show up in your numbers
What you walk away with
A real-time read on whether your launch is landing the way you designed it to
Signal-grounded recommendations your agency can act on in the current campaign cycle
Early warning on patients most at risk — while there is still time to act
Illustrative example
The gap wasn't clinical.
It was expectation management.

A specialty pharma brand six months post-launch was seeing early uptake but higher than expected dropout in the first ninety days. Claims data confirmed the trend. It couldn't explain it.

When the team looked at what patients were saying in the first weeks on therapy, a pattern emerged that no survey had captured: patients weren't stopping because the drug wasn't working. They were stopping because nobody had prepared them for what the first few weeks would actually feel like.

The brand team retooled onboarding materials. Dropout in the comparable cohort the following quarter dropped significantly. The signal was there weeks before the claims data. KEEP was the only source that saw it.

Illustrative example based on real program patterns.
03
Stage Three

Lifecycle Management

Patient perception shifts before it shows up in share data. By the time the trend is visible, you are already behind.

Where you are
4mo
Competitive lead timeKEEP surfaced competitive threat signals four months before a competitor's launch date — giving the brand team time to act proactively.
Competitive threat
Perception shift
Readiness signal
What KEEP changes
Know when patient perception is shifting before it shows up in your numbers
Surface competitive threat signals before patients have made a decision
Identify next best action intelligence for your brand and agency teams
Protect what you've built with intelligence that runs continuously — not quarterly
What you walk away with
An always-on read on how your patient population is thinking and feeling right now
Pre-decision competitive intelligence your agency can act on before the window closes
A continuous signal that compounds — the longer KEEP runs, the more you know
Illustrative example
The window that would have been reactive became proactive.

A brand with three years of traction in a rare liver disease was watching a competitor prepare to enter the market. The brand team knew the launch was coming. What they didn't know was how their own patients were thinking about it.

KEEP surfaced competitive threat signals four months before the competitor's launch date. A segment of enrolled patients was already asking questions about the alternative — not because they were unhappy, but because they were curious and nobody had given them a reason not to be.

A targeted educational campaign was in market before the competitor launched. Patient perception held. The signal arrived early enough to do something with it.

Illustrative example based on real program patterns.
The Compounding Logic

The longer KEEP runs,
the more you know.

Every month of continuous presence adds to the baseline. An insight at month six is only possible because of what the system observed in months one through five. That depth cannot be replicated by starting over with a survey.

Month one is good. Month twelve is irreplaceable. This is not a research project. It is infrastructure.
Always on, never retrospective
Signal captures what's happening now — not what happened last quarter. The window to act is open, not closed.
Compounds with every cycle
18–24 months to reach baseline parity. A competitor starting today would still be building what KEEP already has.
Spans the full lifecycle
Pre-launch, early commercial, lifecycle management. The same system, the same patients, the same compounding intelligence.
Get Started

Your therapeutic category is already in our network.

Name your space. We'll show you what patients are already telling us.

We use cookies to improve your experience, analyze site traffic, and serve relevant content. By continuing to browse, you agree to our use of cookies. Privacy Policy